Sandrine Busseret

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Biomerieux, Inc., Centre National De La Recherche Scientifique, Institut Curie. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandrine Busseret. Retrieved from https://idiyas.com/inventor/sandrine-busseret

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 55.6

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 22(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

where one patent can have more than one assignee

Years Active: 2013-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11193929 - Synthetic bi-epitope compound (2021-12-07),

2. 11009505 - Reagent diluent (2021-05-18),

3. 9890196 - Ezrin assay method for the in vitro diagnosis of colorectal cancer (2018-02-13),

4. 9778260 - Process for the detection and early serotyping of the dengue virus (2017-10-03),

5. 9388404 - Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer (2016-07-12),

6. 9377474 - Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer (2016-06-28),

7. 9062099 - Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer (2015-06-23),

8. 8367806 - Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer (2013-02-05),

9. 8361731 - Ezrin assay method for the in vitro diagnosis of colorectal cancer (2013-01-29),

Title: Sandrine Busseret: Innovator in Immunoassay Technologies

Introduction

Sandrine Busseret is a prominent inventor based in Lyons, France. She has made significant contributions to the field of immunoassays, holding a total of 9 patents. Her innovative work focuses on developing compounds and compositions that enhance the accuracy and efficiency of immunoassay techniques.

Latest Patents

Among her latest patents is a synthetic bi-epitope compound. This compound features a formula where E1 and E2 represent peptide sequences that include at least one epitope of an analyte. The linking arms, represented by X and Y, can be identical or different. The carrier molecule is designed to be soluble, while Z denotes an amino acid derivative with a thiol function prior to bonding with the carrier molecule. This compound can be utilized in various compositions, serving as a control or standard in immunoassays, and is also provided in kits for implementing these assays. Another notable patent is for a reagent diluent, which includes an immunoassay composition comprising an amphipol and a (meth)acrylate monomer-based amphoteric copolymer. This composition is particularly useful as a stabilizer and/or blocking agent.

Career Highlights

Throughout her career, Sandrine has worked with esteemed organizations such as bioMérieux, Inc. and the Centre National de la Recherche Scientifique. Her experience in these institutions has allowed her to refine her expertise in immunoassay technologies and contribute to groundbreaking advancements in the field.

Collaborations

Sandrine has collaborated with notable colleagues, including Jean-Philippe Charrier and Genevieve Choquet-Kastylevsky. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sandrine Busseret's contributions to immunoassay technologies through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to influence advancements in diagnostic methods and improve the reliability of immunoassays.

Profile summary based on public USPTO records.